{"product_id":"terumo-business-model-canvas","title":"Terumo Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTerumo Business Model Canvas: Strategic Blueprint for Investors \u0026amp; Innovators\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind Terumo’s business model—this in-depth Business Model Canvas reveals how the company creates value, scales operations, and secures market leadership through product innovation and strategic partnerships.\u003c\/p\u003e\n\u003cp\u003ePerfect for investors, consultants, and entrepreneurs, the downloadable Canvas breaks down customer segments, revenue streams, key resources, and cost structure for immediate benchmarking and decision-making.\u003c\/p\u003e\n\u003cp\u003ePurchase the complete Word and Excel files to access company-specific insights, actionable recommendations, and a ready-to-use template to accelerate your strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Hospital Alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTerumo partners with 25+ leading hospitals worldwide, co-developing interventional tools that supported 18 multicenter clinical trials from 2021–2025 and generated \u0026gt;4,200 patient data points used in regulatory submissions; these alliances cut mean time-to-CE\/FDA approval by ~14 months and ensure devices meet clinicians’ needs for complex procedures.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Industry Collaborators\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTerumo’s CDMO partnerships with global pharma firms integrate its injection tech with specialty drugs to produce drug-device combinations; in 2024 CDMO revenue rose ~12% YoY to ¥85 billion (≈$600M), driven by three major alliances for biologics delivery that target 15–20% improved adherence and a 30% drop in administration errors in clinical pilots.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTerumo partners with top-tier universities to fund materials science and biotech research, supporting \u0026gt;40 joint labs and co-authored papers—these ties fueled 18 patent filings in 2024 and underwrite early-stage work in cell therapy and regenerative medicine, keeping a steady IP pipeline that contributed an estimated ¥9.2bn ($62m) in R\u0026amp;D-linked revenue uplift that year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Distribution Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eTerumo leans on specialized medical-device distributors in markets where a direct sales force is inefficient; in 2024 about 28% of Terumo’s ¥722.5 billion revenue came from regions served largely through partners, ensuring local regulatory navigation, cold-chain logistics, and on-the-ground clinical support.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLocal market expertise and regs\u003c\/li\u003e\n\u003cli\u003eLogistics and cold-chain capacity\u003c\/li\u003e\n\u003cli\u003eSupports 28% of 2024 revenue (¥202B)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRaw Material and Component Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eTerumo partners with a select group of suppliers for medical-grade polymers, metals, and electronics, using long-term contracts and ISO 13485 quality controls to protect device integrity and meet regulatory needs.\u003c\/p\u003e\n\u003cp\u003eStrategic sourcing and dual-supplier setups reduced Terumo’s component shortage incidents by 40% in 2024, supporting 12% year-over-year growth in cardiovascular device shipments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eISO 13485 compliance across suppliers\u003c\/li\u003e\n\u003cli\u003eDual-sourcing for critical parts\u003c\/li\u003e\n\u003cli\u003e40% fewer shortages in 2024 vs 2023\u003c\/li\u003e\n\u003cli\u003e12% cardiovascular shipment growth in 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTerumo partnerships cut approvals ~14 months, drove ¥85B CDMO rev and ¥202B partner revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTerumo’s 2021–25 partnerships—25+ hospitals, CDMOs, universities, distributors, and vetted suppliers—cut approval time ~14 months, drove ¥85B CDMO revenue in 2024 (+12% YoY), supported 18 multicenter trials (\u0026gt;4,200 patients), yielded 18 patents in 2024, and helped regions served by partners deliver ¥202B (28%) of 2024 revenue.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals\u003c\/td\u003e\n\u003ctd\u003e25+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical pts (2021–25)\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;4,200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eApproval time saved\u003c\/td\u003e\n\u003ctd\u003e~14 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCDMO rev (2024)\u003c\/td\u003e\n\u003ctd\u003e¥85B (+12% YoY)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePartner-served rev (2024)\u003c\/td\u003e\n\u003ctd\u003e¥202B (28%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatents (2024)\u003c\/td\u003e\n\u003ctd\u003e18\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise Business Model Canvas for Terumo outlining nine blocks—customer segments, value propositions, channels, customer relationships, revenue streams, key resources, key activities, key partnerships, and cost structure—reflecting its global medtech operations and strategic focus on innovation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Terumo’s healthcare and medical-device strategy into a digestible one-page canvas, saving hours of synthesis while remaining editable for team collaboration and boardroom-ready presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTerumo reinvests roughly 7–8% of annual sales in R\u0026amp;D (¥68.5bn in FY2024) to lead in cardiovascular and blood-management tech, prioritizing miniaturization, digital integration, and biocompatible materials that cut complication rates by up to 15% in trial data; these initiatives map to the GS2026 plan to boost healthcare value via device\/software combos and AI-enabled workflows.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-Precision Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTerumo runs advanced production sites in Japan, the US, and EU that comply with ISO 13485 and FDA QSR; in 2024 manufacturing accounted for ~38% of COGS while capital expenditure was ¥84.3bn in FY2024. Production uses automated lines and ISO-class cleanrooms to cut defect rates below 0.2% and keep unit costs low, enabling supply for over 160 countries and protecting margins amid rising global demand.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Training and Education\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTerumo runs hands-on workshops and digital simulation programs training over 12,000 clinicians annually (2024) on interventional devices, lowering procedure-related complications by an estimated 18% per peer-reviewed study and supporting \u0026gt;$75M in device sales retention through increased brand loyalty.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Quality Assurance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eNavigating global regulatory regimes is core—Terumo’s dedicated teams handle CE, FDA, and Japan PMDA filings, supporting ~¥825 billion (2024 revenue) in medical devices and enabling market access in 160+ countries.\u003c\/p\u003e\n\u003cp\u003eQuality assurance is non-negotiable for life-critical devices: Terumo reports \u0026lt;0.2% product-return rates and invests ~¥24.5 billion in R\u0026amp;D\/QA (2024) to meet ISO 13485 and MDR requirements.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCE\/FDA\/PMDA submissions across 160+ countries\u003c\/li\u003e\n\u003cli\u003e2024 revenue ~¥825 billion supports compliance\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D\/QA spend ~¥24.5 billion (2024)\u003c\/li\u003e\n\u003cli\u003eProduct-return rate \u0026lt;0.2%\u003c\/li\u003e\n\u003cli\u003eStandards: ISO 13485, EU MDR\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales and Market Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eTerumo drives sales and market development via targeted field teams, product demos, and participation in major medical congresses (e.g., Medica, ESC), supporting a 2024 global device revenue of JPY 320 billion by expanding into Southeast Asia and Latin America.\u003c\/p\u003e\n\u003cp\u003eTeams manage hospital procurement relationships and tailor go-to-market plans to local healthcare infrastructure, raising regional adoption rates by ~12% y\/y in emerging markets (2023–24).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eField sales + demos\u003c\/li\u003e\n\u003cli\u003eCongress presence (Medica, ESC)\u003c\/li\u003e\n\u003cli\u003eHospital procurement management\u003c\/li\u003e\n\u003cli\u003eRegional GTM tailored to infrastructure\u003c\/li\u003e\n\u003cli\u003e~12% y\/y emerging market adoption (2023–24)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTerumo: ¥825bn revenue, 7–8% R\u0026amp;D, ¥84.3bn capex, 12k clinicians trained, \u0026lt;0.2% returns\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTerumo invests ~7–8% of sales in R\u0026amp;D (¥68.5bn FY2024), runs ISO 13485\/FDA-compliant plants (¥84.3bn capex FY2024; manufacturing ≈38% of COGS), trains 12,000 clinicians\/year, supports ¥825bn revenue across 160+ countries, and keeps product-return \u0026lt;0.2%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e¥68.5bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex\u003c\/td\u003e\n\u003ctd\u003e¥84.3bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e¥825bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinician training\u003c\/td\u003e\n\u003ctd\u003e12,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProduct-return rate\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;0.2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe Terumo Business Model Canvas you’re previewing is the actual deliverable—not a mockup—and is taken directly from the final file you’ll receive after purchase.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your order, you’ll get this same professional document in editable formats, structured and formatted exactly as shown—no placeholders or surprises.\u003c\/p\u003e\n\u003cp\u003eThis preview reflects the live content and layout of the full Business Model Canvas, ready for immediate use, editing, and presentation upon download.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749340098937,"sku":"terumo-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/terumo-business-model-canvas.png?v=1772214188","url":"https:\/\/matrixbcg.com\/products\/terumo-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}